U.S. Nootropics Market Size To Reach $4.26 Billion By 2033

U.S. Nootropics Market Growth & Trends

The U.S. nootropics market size is estimated to reach USD 4.26 billion by 2033, growing at a CAGR of 11.6% from 2026 to 2033, according to a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.

The capsules/tablets segment accounted for the largest share in 2025, supported by strong consumer familiarity, convenience, and well-established supplement consumption patterns. Consumers in the U.S. commonly use vitamins, minerals, and wellness supplements in capsule or tablet form, making nootropic products in these formats easier to adopt and incorporate into daily routines. Their leading market position is further reinforced by accurate dosing and product consistency, as capsules and tablets deliver standardized ingredient quantities that attract consumers seeking reliable benefits for focus, memory, and productivity.

The offline segment accounted for the largest share in 2025, highlighting the ongoing significance of physical retail channels in the U.S. nootropics market. Pharmacies, supermarkets, health stores, and specialty nutrition outlets continue to serve as major purchasing destinations, as consumers prefer in-store shopping to examine packaging, check ingredient labels, and understand dosage details before buying. This is particularly important for first-time buyers who seek trust and guidance from pharmacists or store personnel. In addition, immediate product availability, promotional displays, and the convenience of directly comparing products have further strengthened the dominance of offline channels in the U.S. nootropics industry.

Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market.

 Request a free sample copy or view report summary: U.S. Nootropics Market Report

U.S. Nootropics Market Report Highlights

• Based on form, the drinks segment is expected to register the fastest CAGR of 12.5% from 2026 to 2033, fueled by growing consumer demand for convenient and fast-acting cognitive wellness solutions. Increasingly busy lifestyles and rising preference for on-the-go products are encouraging consumers to move away from traditional capsules and tablets toward ready-to-drink formats that can be easily incorporated into everyday routines.

• Based on form, the capsules/tablets segment accounted for the highest revenue share of 41.9% in 2025, driven by widespread consumer familiarity, ease of use, and established supplement consumption patterns.

• Based on distribution channel, the online segment is anticipated to witness the fastest CAGR of 12.0% from 2026 to 2033, fueled by increasing consumer preference for convenience, broader product availability, and digital-first shopping experiences. E-commerce platforms, brand websites, and online marketplaces enable consumers to compare ingredients, prices, reviews, and formulations in one place, helping them make well-informed purchasing decisions.

U.S. Nootropics Market Segmentation

Grand View Research has segmented the U.S. nootropics market report based on the form and distribution channel:

U.S. Nootropics Form Outlook (Revenue, USD Billion, 2021 - 2033)

• Capsules/Tablets

• Powder

• Drinks

• Others

U.S. Nootropics Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

• Offline

• Online

List of Key Players in the U.S. Nootropics Market

• Onnit Labs, Inc. (Unilever)

• Reckitt Benckiser Group PLC

• Mind Lab Pro

• TruBrain (Triplepulse)

• Nooflux

• Zhou Nutrition

• Nootropics Depot

• Neutonic

• Amway Corp.

• Natural Stacks